Lipoglycopeptide Antibacterial [EPC]

729 reported adverse events

Drugs of this class: ORITAVANCIN

These side effects are most commonly reported by patients taking drugs of the Lipoglycopeptide Antibacterial [EPC] class:

# Side effect Count
0 OFF LABEL USE 153
1 PRURITUS 140
2 URTICARIA 88
3 RASH 71
4 BACK PAIN 61
5 CHILLS 56
6 DYSPNOEA 55
7 NAUSEA 53
8 ERYTHEMA 50
9 CHEST PAIN 46
See all common reactions for Lipoglycopeptide Antibacterial [EPC]

Drugs of the Lipoglycopeptide Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ACCESS SITE RUPTURE 2 0.1538
1 RED MAN SYNDROME 38 0.0423
2 INFUSION SITE STREAKING 2 0.0303
3 PERIORBITAL ABSCESS 1 0.0286
4 INFUSION SITE HYPOAESTHESIA 1 0.0222
5 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 1 0.0133
6 INJECTION SITE THROMBOSIS 2 0.0087
7 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 2 0.0078
8 PRODUCT RECONSTITUTION QUALITY ISSUE 2 0.0057
9 INFUSION SITE PHLEBITIS 1 0.0053
See all enriched reactions for Lipoglycopeptide Antibacterial [EPC]